Krystal Biotech Inc. (NASDAQ: KRYS) announced that the Food and Drug Administration approved a label update for VYJUVEK that expands ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE